New Drug Approvals

JULY 18, 2025

3] It was discovered for the treatment of hepatitis C [4] and has since been investigated for use against other viral diseases such as AIDS and COVID-19 , [2] [5] for which it was granted conditional approval in China. [6] It was approved in China in 2021 as a first-in-class treatment for human immunodeficiency virus (HIV).

RNA

Drug Target Review

MARCH 12, 2024

For example, bile acid treatments have been effective against SARS-Cov-2 infections. Bile acids and bile activated receptors in the treatment of Covid-19. Biochemical Pharmacology. Gut Microbes. 2023 February 5 [2024 March 11]; 15(1). Available from: [link] 2 Biagoli M, Distrutti E, Fiorucci S, et al.

Disease

Drug Target Review

JUNE 6, 2023

In this IO arena, we continue to search for additional treatments that can further benefit patients. Immune checkpoint inhibitors, a well-established class of IO treatments, are designed to improve the ability of T-cells to fight cancer by removing inhibitory or suppressive mechanisms that may dampen the anti-cancer functions of T cells.

Engineering

New Drug Approvals

APRIL 19, 2025

“Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors” Biochemical Pharmacology. g, 86%, MC70 ). 3] [4] [5] As of March 2024, it is in phase 2 clinical trials. [1] 1] References ^ Jump up to: a b “Rhythm Pharmaceuticals” AdisInsight. 13 March 2024. .; Stewart, Gregory D.;

Biochemical Pharmacology